84 related articles for article (PubMed ID: 18977669)
1. The role of salvage treatment in advanced colorectal cancer.
Capdevila J; Ramos FJ; Macarulla T; Elez E; Tabernero J
Crit Rev Oncol Hematol; 2009 Jul; 71(1):53-61. PubMed ID: 18977669
[TBL] [Abstract][Full Text] [Related]
2. [Systemic treatment of metastatic colorectal cancer].
Montemurro M; Achtari L; Röth A; Halkic N; Luthi F; Ozsahin M; Denys A; Bauer J; Demartines N; Leyvraz S
Rev Med Suisse; 2008 May; 4(158):1254-7. PubMed ID: 18616207
[TBL] [Abstract][Full Text] [Related]
3. [Second-line chemotherapy for colorectal cancer].
Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
5. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.
Chiappa A; Makuuchi M; Lygidakis NJ; Zbar AP; Chong G; Bertani E; Sitzler PJ; Biffi R; Pace U; Bianchi PP; Contino G; Misitano P; Orsi F; Travaini L; Trifirò G; Zampino MG; Fazio N; Goldhirsch A; Andreoni B
Crit Rev Oncol Hematol; 2009 Oct; 72(1):65-75. PubMed ID: 19147371
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
7. Progresses in the medical treatment of advanced colorectal cancer.
Sultan-Amar V; Fabre-Guillevin E; Piedbois P
Rocz Akad Med Bialymst; 2005; 50():97-100. PubMed ID: 16358946
[TBL] [Abstract][Full Text] [Related]
8. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
9. First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?
Loupakis F; Masi G; Vasile E; Falcone A
Curr Opin Oncol; 2008 Jul; 20(4):459-65. PubMed ID: 18525344
[TBL] [Abstract][Full Text] [Related]
10. [Advance of salvage chemotherapy for colorectal cancer].
Aiba K; Natori K
Gan To Kagaku Ryoho; 2015 Apr; 42(4):394-7. PubMed ID: 25963685
[TBL] [Abstract][Full Text] [Related]
11. Second-line management of metastatic colorectal cancer.
Gallagher DJ; Kemeny N
Clin Colorectal Cancer; 2008 Jan; 7(1):25-32. PubMed ID: 18279574
[TBL] [Abstract][Full Text] [Related]
12. Updated options for liver-limited metastatic colorectal cancer.
Alberts SR
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
[TBL] [Abstract][Full Text] [Related]
13. Update on chemotherapy for advanced colorectal cancer.
Haller DG
Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):11-5. PubMed ID: 11301834
[TBL] [Abstract][Full Text] [Related]
14. Second-line therapy for esophageal cancer.
Martin MG; Govindan R; Morgensztern D
Expert Rev Anticancer Ther; 2007 Jun; 7(6):871-6. PubMed ID: 17555397
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Braun MS; Quirke P; Seymour MT
Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
[TBL] [Abstract][Full Text] [Related]
16. Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting.
Gallagher DJ; Milowsky MI; Bajorin DF
Cancer; 2008 Sep; 113(6):1284-93. PubMed ID: 18629841
[TBL] [Abstract][Full Text] [Related]
17. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
18. Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer.
Arkenau HT; Brunetto AT; Barriuso J; Olmos D; Eaton D; de Bono J; Judson I; Kaye S
Oncology; 2009; 76(3):151-6. PubMed ID: 19169046
[TBL] [Abstract][Full Text] [Related]
19. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]